Literature DB >> 21253436

Molecular Roles of Cdk5 in Pain Signaling.

Elias Utreras1, Akira Futatsugi, Tej Kumar Pareek, Ashok B Kulkarni.   

Abstract

Injury and inflammation trigger activation of several critical cellular pathways in nociceptive signaling in the peripheral nervous system, but their precise molecular mechanisms have not been clearly defined. Cyclin-dependent kinase 5 (Cdk5), a serine/threonine kinase, is mainly expressed in the post-mitotic neurons, and has many important roles in the development, functions and pathophysiology of diseases of the nervous system. Although many functional roles of Cdk5 have been identified in neurons, its precise role in pain signaling has not been well determined. Experimental inflammation in the hind paws of mice resulted in increased mRNA and protein levels of Cdk5 and its activator p35, as well as the Cdk5 activity in nociceptive neurons (Pareek et al., 2006). Furthermore, we also identified that Cdk5 phosphorylates transient receptor potential vanilloid 1 (TRPV1), a key receptor that modulates agonist-induced calcium influx in the neurons (Pareek et al., 2007). We subsequently demonstrated that inflammation triggers increase in Cdk5 activity through activation of early growth response 1 (Egr-1) and p35 expression by tumor necrosis factor alpha (TNF-α) (Utreras et al., 2009). These findings suggest that Cdk5 plays an important role in pain signaling and therefore Cdk5 and its activators are potentially important drug targets for development of novel analgesics to treat neuropathic pain.

Entities:  

Year:  2009        PMID: 21253436      PMCID: PMC3022326          DOI: 10.1016/j.ddstr.2009.04.004

Source DB:  PubMed          Journal:  Drug Discov Today Ther Strateg        ISSN: 1740-6773


  76 in total

1.  Preserved acute pain and reduced neuropathic pain in mice lacking PKCgamma.

Authors:  A B Malmberg; C Chen; S Tonegawa; A I Basbaum
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

Review 2.  The role of voltage-gated calcium channels in pain and nociception.

Authors:  Valentin K Gribkoff
Journal:  Semin Cell Dev Biol       Date:  2006-09-23       Impact factor: 7.727

3.  Enhanced activation of Ca2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35.

Authors:  Tomohisa Hosokawa; Taro Saito; Akiko Asada; Toshio Ohshima; Makoto Itakura; Masami Takahashi; Kohji Fukunaga; Shin-Ichi Hisanaga
Journal:  J Neurosci Res       Date:  2006-09       Impact factor: 4.164

4.  Prenatal cocaine and morphine alter brain cyclin-dependent kinase 5 (Cdk5) activity in rat pups.

Authors:  Rama Bhat; Gopal Chari; Ravi Rao; David Wirtshafter
Journal:  Neurotoxicol Teratol       Date:  2006-07-05       Impact factor: 3.763

5.  Role of protein kinase A in the maintenance of inflammatory pain.

Authors:  K O Aley; J D Levine
Journal:  J Neurosci       Date:  1999-03-15       Impact factor: 6.167

6.  Phosphatidylinositol 3-kinase activates ERK in primary sensory neurons and mediates inflammatory heat hyperalgesia through TRPV1 sensitization.

Authors:  Zhi-Ye Zhuang; Haoxing Xu; David E Clapham; Ru-Rong Ji
Journal:  J Neurosci       Date:  2004-09-22       Impact factor: 6.167

7.  Expression and activity of cyclin-dependent kinase 5/p35 in adult rat peripheral nervous system.

Authors:  M Terada; H Yasuda; S Kogawa; K Maeda; M Haneda; H Hidaka; A Kashiwagi; R Kikkawa
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

8.  Peripheral inflammation increases Scya2 expression in sensory ganglia and cytokine and endothelial related gene expression in inflamed tissue.

Authors:  Hsiu-Ying T Yang; Kendall Mitchell; Jason M Keller; Michael J Iadarola
Journal:  J Neurochem       Date:  2007-09-12       Impact factor: 5.372

9.  Inflammatory pain: the cellular basis of heat hyperalgesia.

Authors:  Jiehong Huang; Xuming Zhang; Peter A McNaughton
Journal:  Curr Neuropharmacol       Date:  2006-07       Impact factor: 7.363

10.  Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival.

Authors:  Bing-Sheng Li; Wu Ma; Howard Jaffe; Yali Zheng; Satoru Takahashi; Lei Zhang; Ashok B Kulkarni; Harish C Pant
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

View more
  19 in total

Review 1.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

2.  Cdk5 regulates Rap1 activity.

Authors:  Elias Utreras; Daniel Henriquez; Erick Contreras-Vallejos; Cristina Olmos; Alex Di Genova; Alejandro Maass; Ashok B Kulkarni; Christian Gonzalez-Billault
Journal:  Neurochem Int       Date:  2013-02-13       Impact factor: 3.921

3.  Transforming growth factor-β1 regulates Cdk5 activity in primary sensory neurons.

Authors:  Elias Utreras; Jason Keller; Anita Terse; Michaela Prochazkova; Michael J Iadarola; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2012-03-28       Impact factor: 5.157

4.  Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity.

Authors:  R Dixon Dorand; Joseph Nthale; Jay T Myers; Deborah S Barkauskas; Stefanie Avril; Steven M Chirieleison; Tej K Pareek; Derek W Abbott; Duncan S Stearns; John J Letterio; Alex Y Huang; Agne Petrosiute
Journal:  Science       Date:  2016-07-21       Impact factor: 47.728

5.  Rapid, quantitative therapeutic screening for Alzheimer's enzymes enabled by optimal signal transduction with transistors.

Authors:  Son T Le; Michelle A Morris; Antonio Cardone; Nicholas B Guros; Jeffery B Klauda; Brent A Sperling; Curt A Richter; Harish C Pant; Arvind Balijepalli
Journal:  Analyst       Date:  2020-03-11       Impact factor: 4.616

6.  Preso1 dynamically regulates group I metabotropic glutamate receptors.

Authors:  Jia-Hua Hu; Linlin Yang; Paul J Kammermeier; Chester G Moore; Paul R Brakeman; Jiancheng Tu; Shouyang Yu; Ronald S Petralia; Zhe Li; Ping-Wu Zhang; Joo Min Park; Xinzhong Dong; Bo Xiao; Paul F Worley
Journal:  Nat Neurosci       Date:  2012-06       Impact factor: 24.884

7.  Targeted overexpression of tumor necrosis factor-α increases cyclin-dependent kinase 5 activity and TRPV1-dependent Ca2+ influx in trigeminal neurons.

Authors:  Pablo Rozas; Pablo Lazcano; Ricardo Piña; Andrew Cho; Anita Terse; Maria Pertusa; Rodolfo Madrid; Christian Gonzalez-Billault; Ashok B Kulkarni; Elias Utreras
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

8.  Cyclin-dependent kinase 5 modulates the P2X2a receptor channel gating through phosphorylation of C-terminal threonine 372.

Authors:  Claudio Coddou; Rodrigo Sandoval; Patricio Castro; Pablo Lazcano; Maria José Hevia; Milos Rokic; Bradford Hall; Anita Terse; Christian Gonzalez-Billault; Ashok B Kulkarni; Stanko S Stojilkovic; Elias Utreras
Journal:  Pain       Date:  2017-11       Impact factor: 7.926

Review 9.  Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors.

Authors:  Francis Giraud; Elisabeth Pereira; Fabrice Anizon; Pascale Moreau
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

10.  TGF-β1 sensitizes TRPV1 through Cdk5 signaling in odontoblast-like cells.

Authors:  Elias Utreras; Michaela Prochazkova; Anita Terse; Jacklyn Gross; Jason Keller; Michael J Iadarola; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2013-05-13       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.